Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cells for moderate refractory ulcerative colitis
ChiCTR1900026035Phase 2Recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- May 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in autoimmune colitis, sponsored by Henan Provincial People's Hospital. Primary endpoints: clinical remission, endoscopic remission and 1 more. Started May 2018; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ChiCTR1900026035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026035.